Skip to main content

University of Helsinki

Support us

ImmunoViroTherapy Lab

News

26.11.2018

Health news

DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer

HOUSTON and HELSINKI, Nov. 13, 2018 /PRNewswire/ -- DNAtrix and Valo Therapeutics today announced an exclusive R&D collaboration to develop...

26.9.2018

Life science news

New cancer vaccine platform a potential tool for tailored and efficacious targeted cancer therapy

Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of...

Pages